1. Home
  2. MDBH vs PSTV Comparison

MDBH vs PSTV Comparison

Compare MDBH & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MDB Capital Holdings LLC common

MDBH

MDB Capital Holdings LLC common

HOLD

Current Price

$3.35

Market Cap

29.0M

Sector

N/A

ML Signal

HOLD

Logo PLUS THERAPEUTICS Inc.

PSTV

PLUS THERAPEUTICS Inc.

HOLD

Current Price

$3.98

Market Cap

28.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDBH
PSTV
Founded
1997
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.0M
28.1M
IPO Year
2022
2016

Fundamental Metrics

Financial Performance
Metric
MDBH
PSTV
Price
$3.35
$3.98
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$55.00
AVG Volume (30 Days)
4.9K
178.0K
Earning Date
05-14-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
87.61
EPS
N/A
N/A
Revenue
N/A
$5,213,000.00
Revenue This Year
N/A
$13.20
Revenue Next Year
N/A
$261.48
P/E Ratio
$4.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.45
$0.13
52 Week High
$5.49
$8.00

Technical Indicators

Market Signals
Indicator
MDBH
PSTV
Relative Strength Index (RSI) 55.50 34.28
Support Level $3.16 $0.36
Resistance Level $3.87 $6.65
Average True Range (ATR) 0.15 0.35
MACD 0.08 -0.03
Stochastic Oscillator 82.93 8.64

Price Performance

Historical Comparison
MDBH
PSTV

About MDBH MDB Capital Holdings LLC common

MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The company operates in two reportable segments: a broker dealer & intellectual property service; and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

Share on Social Networks: